Dr. Bill Harris discusses the need for clinical trials to test the effects of pure DHA versus pure EPA versus a combination of both versus a placebo. He also emphasizes the importance of measuring omega-3 levels at baseline and only allowing people with below-normal levels to participate in the trial.
